Virginia Amador

Sobre mí

Publicaciones destacadas

• Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma

  Autores:

  Sureda-Gomez, Marta; Balsas, Patricia; Rodriguez, Marta-Leonor; Nadeu, Ferran; De Bolos, Anna;

  (...)

  Jares, Pedro; Martin-Subero, Jose, I; Bea, Silvia; Campo, Elias; Amador, Virginia.

  Ver listado completo de autores

  Referencia: Leukemia 2023.

• SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma

  Autores:

  Balsas, Patricia; Veloza, Luis; Clot, Guillem; Sureda-Gomez, Marta; Rodriguez, Marta-Leonor;

  (...)

  Engel, Pablo; Quintanilla-Martinez, Leticia; Klapper, Wolfram; Campo, Elias; Amador, Virginia.

  Ver listado completo de autores

  Referencia: Blood 2021.

• Increased Tumor Angiogenesis in SOX11-positive Mantle Cell Lymphoma

  Autores:

  Petrakis, Georgios; Veloza, Luis; Clot, Guillem; Gine, Eva; Gonzalez-Farre, Blanca;

  (...)

  Martinez, Antonio; Lopez-Guillermo, Armando; Amador, Virginia; Ribera-Cortada, Inmaculada; Campo, Elias.

  Ver listado completo de autores

  Referencia: Histopathology 2019.

• SOX11, a key oncogenic factor in mantle cell lymphoma.

  Autores:

  Beekman, Renee; Amador, Virginia; Campo, Elias;

  Referencia: Current Opinion In Hematology 2018.

• SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.

  Autores:

  Balsas, Patricia; Palomero, Jara; Eguileor, Alvaro; Leonor Rodriguez, Marta; Carmela Vegliante, Maria;

  Planas-Rigol, Ester; Sureda-Gomez, Marta; Cid, Maria C; Campo, Elias; Amador, Virginia.

  Referencia: Blood 2017.

• Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.

  Autores:

  Bea, Slvia; Amador, Virginia;

  Referencia: Current Oncology Reports 2017.

• SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6

  Autores:

  Palomero, J; Vegliante, M C; Eguileor, A; Rodriguez, M L; Balsas, P;

  Martinez, D; Campo, E; Amador, V.

  Referencia: Leukemia 2016.

• Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype

  Autores:

  Ribera-Cortada, Inmaculada; Martinez, Daniel; Amador, Virginia; Royo, Cristina; Navarro, Alba;

  (...)

  Serrano, Sergio; Wotherspoon, Andrew; Colomer, Dolors; Martinez, Antonio; Campo, Elias.

  Ver listado completo de autores

  Referencia: Modern Pathology 2015.

• SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma

  Autores:

  Palomero, Jara; Carmela Vegliante, Maria; Leonor Rodriguez, Marta; Eguileor, Alvaro; Castellano, Giancarlo;

  (...)

  Jares, Pedro; Ribera-Cortada, Inmaculada; Cid, Maria C; Campo, Elias; Amador, Virginia.

  Ver listado completo de autores

  Referencia: Blood 2014.

• Assessment of SOX11 Expression in Routine Lymphoma Tissue Sections Characterization of New Monoclonal Antibodies for Diagnosis of Mantle Cell Lymphoma

  Autores:

  Soldini, Davide; Valera, Alexandra; Sole, Carla; Palomero, Jara; Amador, Virginia;

  (...)

  Johannesson, Henrik; Herrera, Mileyka; Colomo, Lluis; Martinez, Antonio; Campo, Elias.

  Ver listado completo de autores

  Referencia: American Journal Of Surgical Pathology 2014.

Proyectos destacados

• New therapeutic strategies for aggressive mantle cell lymphoma: targeting cancer stem cells and immunecheckpoints

  Investigador/a principal: Virginia Amador Espinosa

  Financiador: Agencia Estatal de Investigación

  Código: PID2021-124048OB-100

  Duración: 01/09/2022 - 31/08/2025

• Tumor-immune microenvironment in mantle cell lymphoma

  Investigador/a principal: Virginia Amador Espinosa

  Financiador: Fundació La Marató de TV3

  Código: 201901-30

  Duración: 30/07/2020 - 31/12/2023

• Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

  Investigador/a principal: Elías Campo Güerri

  Código: 1P01CA229100

  Duración: 01/09/2019 - 31/08/2024

• Tumor immune microenvironment in mantle cell lymphoma progression and control: characterization of critical immune factors and challenges for therapy (TIMSOX)

  Investigador/a principal: Virginia Amador Espinosa

  Financiador: Ministerio de Ciencia e Innovación

  Código: RTI2018-099793-B-I00

  Duración: 01/01/2019 - 31/12/2021

• CIBER de Cáncer

  Investigador/a principal: Elías Campo Güerri

  Código: CB16/12/00225

  Duración: 01/01/2017 - 31/12/2023